London, U.K., Dec. 17, 2021 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced it has been selected for addition to the Nasdaq Biotechnology Index (Nasdaq: NBI), effective as of market open on Monday, December 20, 2021. The NBI is designed to track the…


Previous articlePsychedelics and Substance Use Disorder: 4000 BCE to Present Day
Next articlePTSF89 – A Macro Dive Into Microdosing